Showing results (1911-1920 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|April 12, 2024
Cause-specific death in heart failure across the ejection fraction spectrum: A comprehensive assessment of over 100 000 patients in the Swedish Heart Failure RegistryCamilla Settergren, Lina Benson, Angiza Shahim, et al.
European Journal of Heart Failure|April 8, 2024
Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programmeJoão Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
European Journal of Heart Failure|April 4, 2024
Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registryKarl-Philipp Rommel, Guillaume Bonnet, Vera Fortmeier, et al.
European Journal of Heart Failure|May 24, 2024
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trialCarolyn S P Lam, Lars Køber, Koichiro Kuwahara, et al.
European Journal of Heart Failure|May 23, 2024
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESCGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
European Journal of Heart Failure|May 10, 2024
Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND studyMirjam Kessler, Wolfgang Rottbauer, Ralph Stephan von Bardeleben, et al.
European Journal of Heart Failure|May 15, 2024
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trialMats Christian Højbjerg Lassen, John W Ostrominski, Silvio E Inzucchi, et al.
European Journal of Heart Failure|June 19, 2024
Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FIDNina Nouhravesh, Jyotsna Garg, Frank W Rockhold, et al.
European Journal of Heart Failure|June 18, 2024
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosisSteven A Muller, Belén Peiró-Aventin, Giulia Biagioni, et al.
European Journal of Heart Failure|June 10, 2024
Circulating beta-hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impactLuca Monzo, Jan Kovar, Barry A Borlaug, et al.
Pageof 398